Windlas Biotech receives GMP certification for its new state-of-the-art injectable facility

10 Jan 2025

Windlas Biotech receives GMP certification for its new state-of-the-art injectable facility

Windlas Biotech announced that it has received Good Manufacturing Practices (GMP) certification for its new State-of-the-Art Injectable facility from the Food Safety & Drugs Administration Authority of Uttarakhand, following the inspection in December 2024. The certification states, that the firm is following the Good Manufacturing Practices as per World Health Organization (WHO) TRS Guidelines.

Top Blogs

Recent Article





Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions